ALNYLAM PHARMACEUTICALS INC

Ticker: ALNY CUSIP: 02043Q107 Class: EQTY

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 73,320 Value ($000) $20,165 Avg Close $260.36 Range $231.01 - $287.55

Q2 2024

Shares 59,898 Value ($000) $14,555 Avg Close $157.87 Range $141.98 - $252.87

Q1 2024

Shares 15,443 Value ($000) $2,308 Avg Close $166.82 Range $143.52 - $199.38

Q1 2023

Shares 12,901 Value ($000) $2,584 Avg Close $210.20 Range $179.19 - $242.39

Q4 2022

Shares 1,240 Value ($000) $295 Avg Close $213.29 Range $181.65 - $242.97

Q2 2021

Shares 8,964 Value ($000) $1,520 Avg Close $146.46 Range $125.08 - $177.53

Q1 2021

Shares 15,056 Value ($000) $2,126 Avg Close $150.49 Range $124.00 - $178.41

Q4 2020

Shares 10,373 Value ($000) $1,348 Avg Close $133.53 Range $119.29 - $148.76

Q4 2019

Shares 1,850 Value ($000) $213 Avg Close $99.70 Range $73.32 - $125.72

Q4 2014

Shares 5,100 Value ($000) $495 Avg Close $92.65 Range $72.80 - $111.49

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	73,320	$20,165	$260.36	$231.01 - $287.55
Q2 2024	59,898	$14,555	$157.87	$141.98 - $252.87
Q1 2024	15,443	$2,308	$166.82	$143.52 - $199.38
Q1 2023	12,901	$2,584	$210.20	$179.19 - $242.39
Q4 2022	1,240	$295	$213.29	$181.65 - $242.97
Q2 2021	8,964	$1,520	$146.46	$125.08 - $177.53
Q1 2021	15,056	$2,126	$150.49	$124.00 - $178.41
Q4 2020	10,373	$1,348	$133.53	$119.29 - $148.76
Q4 2019	1,850	$213	$99.70	$73.32 - $125.72
Q4 2014	5,100	$495	$92.65	$72.80 - $111.49